- For challenging targets, it is often necessary to rigorously characterize target protein activity and optimize screening buffers, which has proved crucial for effective hit identification
- Moreover, there are new screening methods for discovering compounds with novel mechanisms of action, including covalent inhibitors and molecular glues
- These examples illustrate how innovative thinking and a sophisticated approach to DEL screening campaign design can bring success to challenging drug discovery projects
To discover tailored DEL campaigns and innovative hit identification for challenging targets, join X-Chem experts, Dr. Zhen Chen, Ph.D., senior principal research scientist, and Anthony Keefe, Ph.D., senior vice president, Alliance Management and Innovation, for the live webinar on Thursday, Jan. 18, 2024, at 10 a.m. EST (4 p.m. CET/EU-Central).
For more information, or to register for this event, visit DNA-Encoded Library Screening: The Art of Campaign Design.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com
SOURCE Xtalks
